Bahadduri, P.M., Polli, J.E., Swaan, P.W. and Ekins, S. (2010) Targeting Drug Transporters-Combining in Silico and in Vitro Approaches to Predict in Vivo. In: Yan, Q., Ed., Membrane Transporters in Drug Discovery and Development, Springer, Berlin, 65-103. https://doi.org/10.1007/978-1-60761-700-6_4

has been cited by the following article:

• TITLE: Biotechnological Drug Development—The Role of Proteins, Genes, In-Silico, and Stem Cells in Designing Models for Enhanced Drug Discovery

  AUTHORS: Taofik Ahmed Suleiman, Ann Christopher Francis, Abdulwasiu Ibrahim, Adedoyin Owolade Jonn-Joy, Ebenezer Adebiyi, Daniel Tweneboah Anyimadu

  KEYWORDS: Drug Discovery, Biotechnology, Diseases, Genes, Protein, In-Silico, Stem Cells, mRNA, DNA

  JOURNAL NAME: Open Access Library Journal, Vol.10 No.8, August 18, 2023

  ABSTRACT: The application of biotechnology in drug discovery has been discovered to be a promising and resourceful approach for the discovery of novel therapeutic candidates that comes with less time and cost than the traditional ways of drug discovery. This has additionally endowed researchers with the necessary understanding of diseases, which offers exceptional methods for treating patients. Additionally, diagnosis and treatment are becoming increasingly intertwined with the help of biotechnology. Today, researchers in biotechnology deal with the root of diseases and find solutions through therapeutic agents, hence, improving quality of life. The discovery of drugs in recent days is practically challenging without good modeling in biotechnology, this wonderful technique is now being adopted in the discovery of new and effective classes of drugs which include but are not limited to gene therapy, cancer vaccines, proteins, and even enzymes. In this current review, we review the efforts so far in the usage of this approach in drug discovery. The review targets the biotechnological application and design implementation in drug discovery. It explains the use of proteins, genes, in-silico, and stem cells in designing models for enhanced drug discovery, the chemical similarity network for drug discovery, and future recommendations on the integration of AI in biotechnology.